Page 375 

Chapter 11 Haemopoietic and Lympho-Reticular Tissues

Haemopoiesis 376
Haematology – Laboratory Tests 377, 378
Anaemia 379–382
Iron Deficiency Anaemia 383–385
The Megaloblastic Anaemias 386
Pernicious Anaemia (PA) 387–388
Folic Acid Deficiency 389
The Haemolytic Anaemias 390–391
Extrinsic Haemolytic Anaemias 392
Incompatible Blood Transfusion/Haemolytic Disease of the Newborn 393
Haemolytic Disease of the Newborn 394
Extrinsic Haemolytic Anaemias 395–396
Extrinsic Haemolytic Anaemias – Malaria 397
Intrinsic Haemolytic Anaemias 398, 399
Disorders of Haemoglobin Synthesis 400
The Thalassaemias 401
Sickle Cell Disease 402
Anaemia of Chronic Disorders 403
Aplastic Anaemia 404
Polycythaemia 405
Neutrophil Granulocytes 406
Disorders of Neutrophils Agranulocytosis 407
Disorders of Neutrophils 408
Platelets and Coagulation 409
Disorders of Platelets 410
The Coagulation Cascade 411
Inherited Defects of Coagulation 412
Acquired Defects of Coagulation 413
Disseminated Intravascular Coagulation 414
Thrombophilia – Thrombotic Disorders 415
The Lymphoid System 416
Lymphadenopathy 417
Lymphadenopathy – Infections 418
Lymphadenopathy 419
Lymphadenopathy – Non-Infective Causes 420
Spleen 421
Splenomegaly 422–425
Diseases of the Spleen – Miscellaneous 426
Thymus 427, 428
Neoplastic Lymphadenopathy 429
Non-Hodgkin’s Lymphomas 430–432
Plasma Cell Tumours 433, 434
Non-Hodgkin’s Lymphoma – T Cell 435
Hodgkin’s Disease 436, 437
Leukaemias 438, 439
Acute Myeloblastic Leukaemia 440
Chronic Myeloid Leukaemia (CML) 441
Chronic Lymphocytic Leukaemia 442
Acute Lymphoblastic Leukaemia (ALL) 443
Myeloproliferative Disorders 444
  Page 376 

Haemopoiesis

The Derivation of Blood Cells

image

Haemopoiesis in Bone Marrow

image
  Page 377 

Haematology – Laboratory Tests

Investigation of blood diseases depends on examination of 1. peripheral blood and 2. bone marrow.

1. PERIPHERAL BLOOD

Blood count: this is normally done by sophisticated electronic machines.

The main parameters are:

(i) HAEMOGLOBIN (Hb) CONCENTRATION (g/dl whole blood)

Normal values: Male 15.5±2.5: Female 14.0±2.5

(ii) CELL COUNT
Red Cell count: Males 5.5±1.0 ×1012/l. Females 4.8±1.0 × 1012/l.
White Cell Count: 4–11 × 109/l.
Neutrophils – 2.0–7.5 × 109/l.
Lymphocytes – 1.5–4.0 × 109/l.
Monocytes – 0.2–0.8 × 109/l.
Eosinophils – 0.04–0.4 × 109/l.
Basophils – 0.01–0.1 × 109/l.
Platelets – 150–400 × 109/l.
(iii) MEAN RED CELL VOLUME (MCV)
Normal – 85±8 fl (femtolitres)
Also measured are:
MEAN CELL HAEMOGLOBIN
Normal = 29.5±2.5 picograms.
MEAN CELL HAEMOGLOBIN CONCENTRATION (MCHC)
Normal = 33±3 g/dl.

BLOOD FILM – stained by a Romanowski method.

image
  Page 378 

Another useful test is the measurement of the PACKED CELL VOLUME (PCV) or haematocrit.

This is obtained by centrifuging anticoagulated whole blood in a haematocrit tube.

image
2. BONE MARROW EXAMINATION

Examination of bone marrow is important in explaining abnormalities of the peripheral blood.

In the past, aspiration of marrow from the sternum was commonly performed. Now the posterior iliac crest is used – it is safer and allows marrow to be aspirated and a trephine biopsy to be taken.

image

Erythropoiesis

Normal marrow erythropoiesis is said to be NORMOBLASTIC.

image

When the essential factors vit. B12 or folic acid are deficient, the red cell precursors show clear morphological changes – erythropoiesis is said to be MEGALOBLASTIC (p.386).

  Page 379 

Anaemia

The most important function of the red cell is the transport of oxygen bound to haemoglobin. The most common and important disorder associated with disease of the red cells is ANAEMIA, which is defined as a reduction below normal of the concentration of haemoglobin in the blood.

Anaemia in men – Hb < 13 g/dl: in women – < 11.5 g/dl.

Effect of Anaemia

(potential at rest but significant on exertion)

image

Clinical Associations

1. Diminished exercise tolerance, i.e. dyspnoea on exertion.
2. Rapid, full, bounding pulse: decreased circulation time.
  Page 380 

The effects of anaemia depend on its severity, rate of development and duration.

In slowly developing moderate anaemias, symptoms such as dyspnoea only appear on exertion, and even when the haemoglobin falls as low as 6–7 g/dl, clinical features may be slight.

Pathological Complications of Anaemia

1. Effects of degenerative arterial disease are aggravated, e.g. symptoms of ANGINA PECTORIS and lower limb CLAUDICATION are increased.
2. In severe anaemias effects are seen in organs.
image

Note:Therefore blood transfusion used in the treatment of anaemia is given slowly and as packed cells to avoid fluid overload.

In very rapidly developing anaemias, the compensatory mechanisms cannot adjust adequately – the condition merges into shock.

  Page 381 

Causes of Anaemia

An understanding of the four main mechanisms by which anaemia develops depends on a knowledge of the life-cycle of red blood cells.

image

Note: Many forms of anaemia have more than one component.

e.g.

1. The abnormal cells produced in hypoplastic and dyshaemopoietic anaemias have a shortened life span so that a haemolytic element is superimposed.
2. The anaemia of chronic blood loss is almost wholly dyshaemopoietic due to the loss of iron.
  Page 382 

Hypoplastic and Aplastic Anaemias

These are rare conditions and, as the names imply, are due to marrow failure with diminished numbers or absence of haemopoietic cells. Usually all three marrow cell lines are affected, resulting in pancytopenia in the peripheral blood.

Marrow failure of this type is dealt with in detail on page 407.

Marrow failure due to extensive tumour infiltration or fibrosis also occurs.

The anaemias associated with miscellaneous chronic diseases (‘Secondary’ anaemias) are dealt with on page 408.

Dyshaemopoietic Anaemias

The usual cause of these anaemias is deficiency of an essential factor required for proper haemoglobin synthesis or erythroblast maturation and development. They are associated with a hypercellular marrow and are divided into two main groups:

(1) normoblastic and (2) megaloblastic, depending on the type of erythroblastic maturation in the marrow.

  Page 383 

Deficiency of Essential Factor

image

Iron Deficiency Anaemia

IRON DEFICIENCY ANAEMIA is the commonest anaemia on a world basis due to (a) poor nutrition, (b) intestinal parasites (esp. hookworm) causing bleeding and (c) multiple pregnancies.

In Western countries, in the adult male and post-menopausal women, iron deficiency anaemia is nearly always due to gastrointestinal blood loss from cancer, peptic ulceration, aspirin and non-steroidal ingestion, etc. Without IRON the haem component of the haemoglobin molecule cannot be synthesised.

image

Changes in the blood: The red cells which show:

microcytosis (cells smaller — mean diameter < 6.7μm)
hypochromasia (contain less haemoglobin ∴ less well stained)
anisocytosis – variation in size
poikilocytosis – variation in shape
image

Parameter Low/High Normal Range
MCV (mean cell volume) LOW (< 80) 80–92fl
MCH (mean cell haemoglobin) LOW (< 27) 27–32pg
MCHC (mean corpuscular haemoglobin concentration) LOW (< 30) 33 g/dl
Serum IRON LOW 10–30 mmol/l
Serum FERRITIN LOW 15–300 mg/l
Serum IRON BINDING CAPACITY RAISED 45–70 mmol/l
Serum IRON SATURATION image LOW 16–60%

The reticulocyte count is NORMAL except following episodes of haemorrhage. Usually there are no changes in the leucocytes and platelets.

The bone marrow is hypercellular and contains small, poorly haemoglobinised normoblasts; iron stores are reduced.

  Page 384 

Iron Metabolism

Iron is absorbed mainly in the duodenum and upper jejunum. Only small amounts are normally required to replace iron losses. Since the average diet contains more iron than is required, its absorption is controlled by the mucosal apoferritin mechanism.

image

The iron (X) in the diet enters the mucosal cell through an apical uptake transporter (DMT-1) and having combined with apoferritin (O) is retained in the cell as ferritin (⊗).

Iron unbound by apoferritin passes through the cell through a basolateral transporter (ferroportin) and is transported in the blood to join the iron recycling system.

Note: New haemoglobin formed in the bone marrow contains 95% iron from recycling system, 5% from diet.

Note: This bound iron is subsequently shed along with the cell into the lumen.

The state of the iron stores controls the apoferritin (a form of intracellular transferrin) content of the intestinal mucosal cell by a feed-back mechanism.

image

Acute Iron Overload

If a large dose of medicinal iron preparations is taken (particularly by children in error) the absorption and transport mechanisms are overwhelmed and free iron radicals exert very toxic effects.

  Page 385 

The iron balance may be summarised as follows.

INPUT
(Adult male)
BODY IRON
Total 3–6g
OUTPUT
Average: 1 mg/day derived from foods
(a) animal muscle
(b) vegetables.
(a) Functional iron in haemoglobin, myoglobin, enzyme systems, transferrin image 70% at least Average: 1 mg/day
Skin desquamation and miscellaneous secretions
The average diet contains 10–20 mg iron, of which about 10% is absorbed. In the adult female, the average daily input is about 2 mg. (b) Storage iron in liver, spleen, bone marrow as ferritin, haemosiderin image 30% or less Menstruation
This extra loss of about 0.5 to 1 mg requires extra input in the female

Anaemia results when this balance is upset in:

1. Increased output This almost always is caused by blood loss – often small in amount and chronic (1 ml blood = 0.5 mg iron). In the female, uterine bleeding is a common cause, and in both sexes bleeding from the gastrointestinal tract is important.
2. Decreased input
(a) Poor diet (including diets containing substances antagonistic to iron absorption, e.g. phytates, phosphates)
(b) Malabsorption – due to bowel disease, e.g. coeliac disease, or post-surgical, e.g. post-gastrectomy.
3. Increased body requirement
(a) During rapid growth in childhood
(b) In pregnancy.

Usually anaemia develops slowly (except in cases of serious haemorrhage).

  Page 386 
image

The Megaloblastic Anaemias

These dyshaemopoietic anaemias are almost always caused by deficiency of either vitamin B12 or folic acid which are intracellular co-enzymes, particularly important for the synthesis of DNA.

The effects of deficiency occur in most organs of the body but are prominent where cell turnover is rapid, e.g. in the marrow.

image

Results in Organs Particularly Affected

image

Note:

(a) Vit B12 (but not folic acid) has a separate function in the maintenance of the integrity of myelin. Therefore deficiency leads to neuropathies – particularly subacute combined degeneration (p.391).
(b) The marrow and blood appearances are similar in deficiency of vit B12 and folic acid from any cause. The classic disease of this type is pernicious anaemia.
  Page 387 

Pernicious Anaemia (PA)

This serious and severe anaemia was first described by the English physician Addison in the mid 19th century. At that time it was invariably fatal, but now is treatable. It is due to vitamin B12 deficiency and is always associated with achlorhydria and gastric mucosal atrophy, due to autoimmune gastritis.

Vitamin B12 metabolism and causes of deficiency:

image

Released into blood stream bound to transcobalamin to act as important co-enzyme in several intracellular synthetic pathways but particularly of DNA.

  Page 388 

Mechanism of Production of Gastritis

PA is an autoimmune disease. The gastric atrophy is caused by an immune reaction against parietal cell cytoplasmic constituents and specifically by antibodies to intrinsic factor (IF).

image

There is an increased familial incidence of PA and other organ specific autoimmune diseases, e.g. Hashimoto’s thyroiditis.

Blood Changes

There is a pancytopenia, i.e. reduction in RBCs, granulocytes and platelets but the red cells are larger (macrocytosis).

image

Marrow Changes

Hyperplasia – often complete cellularity in flat bones and extension down length of femur.

image

Associated Changes

1. Nervous system
(a) Subacute combined degeneration of spinal cord.

Note: This serious degeneration may occur before clinical anaemia is present, and is aggravated by the administration of folic acid.

(b) Peripheral neuropathy – both sensory and motor loss.
2. Epithelial surfaces

Atrophy is common especially in the tongue and vagina – where senile atrophy is aggravated.

  Page 389 

Folic Acid Deficiency

Folic Acid (Pteroyl-Glutamic Acid) Deficiency

Normal metabolism Deficiency
Source Dietary
Polyglutamines in green vegetables, cereals, meat, fish and eggs (not milk) Low intake of vegetables.
Anorexia, alcoholism, poverty (elderly), infants (late weaning)
Minimum daily requirement Increased requirements
50 μg Pregnancy (fetal growth)
Infancy and childhood (rapid growth)
Body reserves 50–100 days Haemolysis
Malignancy
Absorption Malabsorption
As mono-glutamate in jejunum image Coeliac disease
Surgical by-pass
Utilisation Utilisation block
For DNA synthesis. Vit B12 is necessary for synthesis of the active tetrahydrofolate form (FH4) Drugs e.g. methotrexate in cancer chemotherapy also anti-convulsants e.g. phenytoin.

Note:

1. Since the marrow and blood changes in folic acid and vitamin B12 deficiency are similar, the differential diagnosis has to be obtained by other laboratory tests – particularly the measurement of vit B12 in the serum and of folic acid in RBCs. Special tests of absorption of vit B12 (e.g. Schilling test) are available.
2. Since vit B12 and folic acid deficiency are often associated with malabsorption, other deficiencies (e.g. iron) may co-exist.
3. All megaloblastic anaemias are macrocytic, but not all macrocytic anaemias are megaloblastic.
4. There is a strong association between folic acid deficiency in pregnancy and congenital neural tube defects.
  Page 390 

The Haemolytic Anaemias

Haemolytic Anaemias

In all haemolytic anaemias, there is a reduction in the life span of the red cells; due to an increased rate of red cell destruction – haemolysis.

Red cells may be destroyed

(a) in the spleen, liver – extravascular haemolysis.
(b) in the blood stream – intravascular haemolysis, with release of haemoglobin into plasma.
image

Functional reserve can compensate for a certain level of haemolysis but this fails when the degree of red cell loss is extreme or when the marrow function is compromised by other factors.

  Page 391 

Effects of the Increased Degradation of Haemoglobin

In most haemolytic conditions, the red cells are removed and the haemoglobin degraded in the usual way, i.e. by phagocytosis by the macrophage system.

image

Note:

1. The bilirubin is unconjugated and is attached to protein so that renal excretion does not occur – acholuric jaundice.
2. Unconjugated bilirubin is toxic to the central nervous system of neonates; kernicterus (see p.394) is a serious complication of haemolytic disease of the newborn.
3. If haptoglobin reserves are saturated, Hb remains free in plasma causing kidney damage and haemoglobinuria.

Reactive Bone Marrow Changes

There is a marked hyperplasia ——— Extension of RED MARROW into long bones

image

Many young red cells are released into the blood. The reticulocyte count may be 20–30%.

  Page 392 

Extrinsic Haemolytic Anaemias

The causes of shortened red cell survival are divided into 2 main groups.

1. EXTRINSIC (factors outside the red cells) and 2. INTRINSIC (defects of red cells). Extrinsic haemolytic anaemias fall into 4 groups due to:
(a) ANTIBODIES (either auto-immune or iso-antibodies,
(b) Infections,
(c) Chemical damage to the red cell and
(d) Physical damage to the cell.

(1A) Autoimmune Haemolytic Anaemia

image

Auto-immune haemolytic anaemias are classified according to the temperature at which the reaction occurs and the presence of an underlying cause.

warm (37 °C – usually IgG) cold (< 30 °C – usually IgM)
Primary – so-called idiopathic haemolytic anaemia: usually in adults. Idiopathic cold agglutination disease
(i) lymphomas.
(ii) Mycoplasma pneumoniae.
(iii) viral infections e.g. measles.
Secondary – associated with
(i) lymphomas e.g. chronic lymphocytic leukaemia, Hodgkin’s disease.
(ii) other cancers.
(iii) connective tissue diseases e.g. systemic lupus erythematosus, rheumatoid arthritis.
(iv) drugs e.g. methyl dopa.
Mechanism image
Mechanism:
Coating of RBC with IgG antibodies often against Rhesus ‘e’ antigens. image
Destruction in spleen which is often enlarged.
  Page 393 

Incompatible Blood Transfusion/Haemolytic Disease of the Newborn

(1B) Destruction of RBCS is due to Iso-Antibodies

In these, the antibodies act against antigens which are derived from another individual of the same species.

Incompatible ABO blood transfusion is a classic example.

image

(1C) Haemolytic Disease of the Newborn (HDN)

This occurs in Rhesus positive fetuses conceived by Rh-negative mothers. The usual mechanism is as follows:

First pregnancy: Rh-positive fetus in Rh-negative mother – no antibodies present; ∴ Healthy Baby

But during this pregnancy, iso-immunisation of the mother may occur.

Towards term and particularly during labour the placental barrier is breached and fetal RBCs enter the maternal circulation.

  Page 394 
image

Haemolytic Disease of the Newborn

The basic mechanism is influenced by three important factors:

(a) The maternal immune response tends to be proportional to the number of fetal cells entering the circulation.
(b) The maternal immune response is boosted in successive Rh incompatible pregnancies – the highest maternal antibody titres are found in the latest of multiple pregnancies.
(c) Fetal/maternal ABO compatibility influences the Rh immune response.
image

Subsequent pregnancies: All Rh-positive fetuses conceived by a mother who has acquired anti-Rh antibodies either during previous pregnancies or by blood transfusion (in this case the first fetus also) are at risk.

image

Modern prophylaxis

Injection of anti-Rh antibody minimises immune response.

  Page 395 
image

Extrinsic Haemolytic Anaemias

2. INFECTIONS

There are three mechanisms by which infections cause haemolysis:

image
3. DRUGS AND CHEMICALS

The three main mechanisms by which drugs and chemicals cause haemolysis are:

  Page 396 
image
4. MECHANICAL TRAUMA

The results of damage to red cells within the circulation are:

image

The main circumstances in which red cells are damaged are:

(a) In the heart and great vessels

When the blood flow is subjected to undue turbulence or jet effect. An important example is prosthetic valves in the left side of the heart.

image
(b) In the microcirculation
(i) When the blood flow in arterioles is impeded by strands of fibrin.
image

This condition is called microangiopathic haemolytic anaemia and occurs in many disease states involving small blood vessels e.g. malignant hypertension and/or intravascular coagulation.

(ii) When blood vessels are subjected to direct trauma. This is seen classically in military recruits marching long distances in hard soled boots, when the blood vessels of the soles of the feet are squeezed with every step – march haemoglobinuria.

The haemolysis is usually not severe enough to be of clinical significance, but haemoglobinuria may cause alarm.

Other causes of haemolysis include:

Hypersplenism

In enlargement of the spleen from any cause, the sequestration of red cells is increased so that haemolytic anaemia may result.

  Page 397 
image

Extrinsic Haemolytic Anaemias – Malaria

Malaria is an endemic disease in many parts of Africa, Asia, Central and South America. Many millions of cases occur each year and the mortality is at least 1%. The disease is particularly severe in non-immune subjects from temperate climates; in endemic areas where the ‘herd’ immunity is high, a low grade chronic illness is common.

Female anopheline mosquitos act as intermediate hosts in the life cycle of the parasite, a protozoon (genusPlasmodium).

  Page 398 
image

Intrinsic Haemolytic Anaemias

Intrinsic Defects – Usually Hereditary

In

(i) cell membrane
(ii) enzymes
(iii) molecular structure of haemoglobin (haemoglobinopathies).
image
1. Cell membrane defects
(a) Hereditary spherocytosis: the majority of cases are familial (autosomal dominant).
image

The primary defect is in the proteins which support the plasma membrane – SPECTRIN and ANKYRIN.

The cells assume a spherical shape due to instability of the plasma membrane.

Premature sequestration and destruction in splenic pulp. Splenomegaly is common.

Note: Splenectomy is usually ‘curative’ but the red cell defect remains.

The severity of the haemolysis is variable; many cases are compensated and not anaemic, but crises are common, e.g. if folate deficiency supervenes. Intercurrent infections may precipitate increased red cell destruction with jaundice or temporary bone marrow hypoplasia, e.g. parvovirus infection, with severe anaemia.

The laboratory diagnosis depends on:

(1) typical blood film with spherocytes,
(2) high reticulocyte count and
(3) increased osmotic fragility of RBCs.
(b) Hereditary elliptocytosis is similar to spherocytosis in many respects, but it is usually not severe enough to cause anaemia or jaundice. Haemolysis is usually mild.
(c) Hereditary abetalipoproteinaemia: a rare disease in which the red cell membranes are abnormal and the cells become spiky (acanthocytes).
image
(d) Paroxysmal nocturnal haemoglobinuria – a rare, acquired condition in which anchorage of proteins to the red cell membrane is abnormal. The cells are particularly susceptible to the action of complement (usually activated by the alternative pathway) at low pH. Intravascular haemolysis results.
  Page 399 
2. Enzyme defects

Usually hereditary. Glucose is the source of energy with which the red cell metabolism is maintained. Glycolysis is effected by two classic enzyme pathways.

The following simplified diagram outlines the pathways and indicates only the main enzymes and substrates.

image

Over 400 different subtypes of G-6PD are described with a spectrum of activity. In G-6PD deficiency, a common defect especially in Africa, spontaneous anaemia is not common, but crises with anaemia and Heinz body formation occur under oxidant stress, e.g. chemicals and drugs; favism (bean products). The presence of the defect may seriously aggravate haemolysis due to other causes, e.g. haemolytic disease of the newborn.

G-6PD deficiency shows X-linked inheritance so that in the male the defect is fully expressed, while in the female heterozygote there are two populations of red cells in the blood (1) normal cells and (2) defective cells.

In both these defects and in the rare defects of other enzymes in the pathways which have been described the expression of the abnormal gene is very variable from case to case.

  Page 400 

Disorders of Haemoglobin Synthesis

3. Haemoglobinopathies

Varieties of normal haemoglobin are illustrated:

Normal Haemoglobin Molecule

4 subunits each consisting of a haem core with a polypeptide chain attached. The haem core is constant while the polypeptide chains occur in pairs. 4 different polypeptide chains occur normally.

image

There are 3 types of normal haemoglobin.

image

Fetal haemoglobin is replaced by adult haemoglobin during the first year (‘haemoglobin switching’). Note that the α chain occurs in all normal haemoglobins.

Two copies of the α chain genes (αα/αα) are present on chromosome 16; β, γ and δ genes are found in a complex on chromosome 11. A number of globin-like genes are also present but are omitted for simplicity.

In the thalassaemias and haemoglobinopathies there are abnormalities in the production and structure of haemoglobin chains due to mutation of these genes.

  Page 401 

The Thalassaemias

These are inherited disorders in which synthesis of globin chains is diminished or absent.

They are common in the Mediterranean, Middle East and India.

α-thalassaemia – reduction of α chain synthesis.
β-thalassaemia – reduction of β chain synthesis.
image

The severity of the disease depends on (i) the degree of globin chain abnormality and (ii) whether the patient is homozygous or heterozygous for the defect.

There are normally 4 α genes (αα/αα).

In the α-thalassaemias the genetic defects are illustrated as follows:

image
1. Hb-Barts hydrops syndrome (– –/ – –)

All 4 genes for the α chain are absent. Fetal Hb cannot be formed and the fetus dies in utero.

2. Hb-H disease (– α / – –): only one α gene is present.

This leads to an excess of β chains which form tetramers called Hb-H.

There is a moderate microcytic hypochromic anaemia with splenomegaly.

3. α-thalassaemia traits (– α / – α): even if two α genes are absent, the remaining two are active and the symptoms and anaemia are usually mild.

β-Thalassaemia

β-thalassaemia major – two defective β genes.

The excess of α genes leads to severe anaemia with haemolysis. The marrow becomes hyperplastic and there is atrophy of bones. The main form of haemoglobin is HbF – which persists into adult life.

β-thalassaemia minor – one defective β gene.

The anaemia is mild. The red cells are microcytic and hypochromic and a mistaken diagnosis of iron deficiency anaemia can be made. These subjects act as carriers for β-thalassaemia major.

  Page 402 

Sickle Cell Disease

This disorder is very common in Central Africa but also occurs in the Mediterranean, Middle East and India. It affects the black population of USA and the Caribbean.

It is due to a mutation in the β chain of haemoglobin (the amino-acid glutamic acid is substituted by valine) and is inherited as an autosomal recessive trait.

The effects are mild in heterozygotes (Hb AS) = sickle cell trait; they are severe in homozygotes (Hb SS) = sickle cell anaemia.

The effects are summarised as follows:

1. At molecular level HbS becomes less soluble in low levels of oxygen tension.
image
2. In the red cell this causes distortion (sickling).
image
3. In tissues
image

Acute sickle cell crises are often provoked by:

(1) infection, (2) cold, (3) low pO2 e.g. flying in unpressurised aircraft.

In addition, infection, especially by parvoviruses in childhood, may provoke an aplastic anaemia crisis.

Note: HbS confers resistance to malaria: in terms of evolution this confers a survival benefit to those carrying the HbS gene.

  Page 403 

Anaemia of Chronic Disorders

This term describes the anaemias seen commonly in patients with chronic diseases

e.g.

(ia) Chronic inflammation e.g. rheumatoid arthritis, SLE
(ib) Chronic infection e.g. T.B.
(ii) Malignancy.

The anaemia is usually mild (Hb > 9 g/dl).

image

In addition, malignant tumour growth may cause anaemia by 2 more specific mechanisms.

(a) Chronic bleeding from the surface of an ulcerated tumour – especially from the alimentary tract → iron deficiency.
(b) Replacement of the bone marrow by malignant tumour.

Normocytic Normochromic Anaemias are also found in other systemic diseases.

  Page 404 
image

Aplastic Anaemia

In this rare disorder there is:

image

There are a number of different types

(a) Idiopathic – in 2/3 of cases no cause is found.
(b) Drug induced – this may be:
(i) Predictable e.g. Cytotoxic chemotherapy.
(ii) Idiosyncratic e.g. Chloramphenicol (1 in 25 000–60 000 affected). Phenylbutazone.
(c) Virus induced e.g. Hepatitis, Epstein–Barr Virus.
(d) Autoimmune.
(e) Inherited e.g. Fanconi’s anaemia – Autosomal recessive.

Treatment This consists of:

(a) Supportive therapy e.g. blood transfusion.
(b) Attempts to restore haemopoiesis e.g. bone marrow transplantation,
anabolic steroids,
immunosuppressive therapy,
withdrawal of causative drugs.

The Sideroblastic Anaemias

In these rare anaemias, failure of synthesis of the haem component of the haemoglobin molecule is indicated by the presence of a ring of iron granules around the normoblast nucleus.

image

The condition arises secondarily in many of the chronic disease states mentioned on the previous page, or as a result of drug treatment or chemical poisoning (e.g. lead). Some cases are ‘primary’ – representing a form of myelodysplasia.

The anaemia is usually dimorphic; i.e. showing hypochromic and macrocytic features combined.

  Page 405 

Polycythaemia

Polycythaemia

Polycythaemia (erythrocytosis) is defined by a haemoglobin level above the normal range: in true polycythaemia the red cell mass is increased and the haematocrit is always elevated.

image

Note: Relative Polycythaemia is the result of fluid loss with a decrease in plasma volume and a normal red cell mass.

Aetiology

There are two types:

Secondary Polycythaemia

The red cell increase is the result of increased stimulation of marrow by erythropoietin. Two main groups of conditions are associated with this:

image

Primary Polycythaemia (Polycythaemia Rubra Vera)

This is a myeloproliferative disorder with increased red cell production. It may be associated with an increase in other marrow elements. Splenomegaly is usually present. A minority of patients develop acute leukaemia.

Effects of Polycythaemia

(a) There is usually a distinctly florid complexion.
(b) Increased blood viscosity causes arterial and venous thrombosis.
(c) Increased marrow activity → increased uric acid metabolism → tendency to gout.
  Page 406 

Neutrophil Granulocytes

Neutrophil Neutrophil Granulocyte (Polymorphonuclear Leucocyte)

The essential function of these cells is protection against microbial infection by phagocytosis and killing. They are produced alongside red blood cells, platelets and monocytes from a common stem cell in the marrow.

Marrow Production - Stained by a Romanowski Method

image

Note the nuclear changes progressing from large open nucleus and several nucleoli to the mature condensed multi-lobed state. The cytoplasm matures with the acquisition of specific granules.

image

An increase in the number of circulating neutrophils reflects an increased activity in the tissues at the site of an acute inflammatory reaction

  Page 407 

Neutrophil Activation

image

Disorders of Neutrophils – Agranulocytosis

Although a common finding in many bacterial infections, neutrophil leucocytosis does not occur in: (a) some acute bacterial infections, e.g. typhoid fever, brucellosis, (b) many chronic bacterial infection, e.g. TB, (c) most virus infections unless acute bacterial infection or necrosis occurs, (d) overwhelming infections with severe toxaemia.

In the absence (agranulocytosis) or diminished numbers of neutrophils – < 2.5 × 10/1 (2500/mm3) increased susceptibility to infection results.

image

Drugs may act in the following ways:

  Page 408 
image

Disorders of Neutrophils

Disorders of Neutrophil Function

Divided into 3 groups: (1) chemotaxis, (2) microbial phagocytosis and (3) microbial kill.

Chemotaxis and phagocytosis may be defective due to:

(a) an intrinsic defect of the neutrophils e.g. leucocyte adhesion deficiency – reduction of B2 integrin expression.
(b) plasma deficiency of chemotactic factors and opsonins – seen especially when there are deficiencies in the complement cascade.

Microbial kill fails when there is an intracellular enzyme defect e.g. in chronic granulomatous disease (CGD) and the Chediak–Higashi syndrome where the neutrophils contain abnormal giant granules.

The normal sequence following phagocytosis is:

image
(a) Bacterium digested by acid hydrolases and other enzymes
(b) Neutrophil degranulated

Chronic Granulomatous Disease (CGD)

It is a rare hereditary disorder in which the neutrophils have normal phagocytic function but are unable to kill certain bacteria. The disease is fully expressed only in males. It presents as multiple chronic abscesses and granulomas affecting skin, lungs, bones, spleen and liver.

The rapid production of H2O2 is defective (in the neutrophils and also in macrophages due to deficiency of NADPH-oxidase).

image

About 2/3 of cases are X-linked (fully expressed in males): the remainder are recessive. The neutrophils are unable to reduce nitroblue tetrazolium (used as a diagnostic slide test).

  Page 409 

Platelets and Coagulation

These small, non-nucleated discs, derived from the cytoplasm of the bone marrow megakaryocytes, are released into the blood stream by a budding process.

image

Platelets contain von Willebrand factor, adenosine diphosphate (ADP), vasoactive amines including serotonin (5HT) and histamine and phospholipid

Their main role is in preventing blood loss after injury.

  Page 410 

e.g. skin wound.

image

Abnormalities of Coagulation

image

Disorders of Platelets

Disorders of the platelets include:

(a) deficiencies of number – thrombocytopenia – lead to bleeding tendency.
(b) defective function.

Thrombocytopenia

Although the normal platelet count ranges from 150–400 × 109/l, a risk of dangerous spontaneous haemorrhage is unusual unless the count falls below 30 × 109/l.

The causes of thrombocytopenia fall into two main groups:

image

PURPURA is the term used for disorders involving bleeding from capillaries, with the production of small petechial spots. Mild to moderate thrombocytopenia or defective platelet formation are the usual causes. Two examples are illustrative:

1. Idiopathic thrombocytopenic purpura is due to auto-immune destruction of platelets. Antibodies are directed against platelet membrane glycoproteins.
(a) Acute: mainly in children, provoked by viral infection: it is usually self-limiting in a few weeks.
(b) Chronic: mainly in young women with an insidious onset and lasting many years: splenectomy is often required (the spleen is the major site of platelet destruction).
2. Defective platelet function has many forms – von Willebrand’s disease (vWD) is the commonest. The gene encoding vWF is located on chromosome 12.

vWF is a large protein which potentiates the binding of platelets to subendothelial collagen and also acts as a carrier for coagulation factor VIII.

image

THROMBOCYTOSIS (increased platelet numbers) may occur in a mild form (with no clinical significance) reactive to a variety of disorders of chronic inflammation and cancer. Larger counts are seen in myeloproliferative disorders (e.g. essential thrombocytosis, chronic myeloid leukaemia) and are of serious clinical significance due to thrombosis.

  Page 411 

The Coagulation Cascade

The coagulation of blood is the result of conversion of FIBRINOGEN to FIBRIN, but the chemical pathway leading to this final phase is a complicated cascade in which inert coagulation factors are serially activated. At each step augmentation takes place.

image

Note: ‘a’ denotes activated form

The system contains several feed-back loops (not illustrated) which can inhibit the cascade at various levels.

Anti-thrombin III and the protein C/protein S system are powerful inhibitors preventing uncontrollable coagulation.

Vitamin K is required for the production of factors II, VII, IX and X. calcium ions and phospholipids (mainly derived from platelets) are essential for many of the steps in thrombin production. Once thrombin is formed, it appears to stimulate several of the preceding reactions and also the polymerisation of fibrin.

Fibrinolytic System – This occurs following fibrin deposition as a protective mechanism against excess coagulation.

  Page 412 
image

Inherited Defects of Coagulation

These are less common than acquired abnormalities, but are of considerable importance.

Haemophilia A

Haemophilia is due to deficiency of Factor VIII – an essential cofactor in the activation of Factor X in the intrinsic system.

image

Factor VIII is encoded by a gene on the long arm of the X chromosome – haemophilia is inherited as an X-linked recessive, i.e. almost all patients are male. Their mothers are usually carriers, but about 30% of cases are due to new mutations. Around 1 in 10 000 is affected.

Clinical Features

The severity depends on the levels of Factor VIII.

    Level of Factor VIII
Severe: Frequent spontaneous bleeding.  
    <2% of normal
Moderate: Bleeding after minor trauma – rarely spontaneous. 2–10%
Mild: Bleeding severe only after major trauma or surgery. 10–50%

Important sites of bleeding are:

image

Note: In the past, the use of virus infected Factor VIII in treatment has caused HIV (AIDS) and Hepatitis C infection. Similar concerns apply to variant CJD (p.555).

Haemophilia B (Christmas Disease)

This is due to deficiency of Factor IX – also carried by a gene on the X chromosome. The clinical features are similar, but the prevalence is lower (1 in 30 000 males).

Rarely deficiencies of other coagulation factors are seen, e.g. fibrinogen, Factor XI and Factor V.

They are treated by infusion of the appropriate factors.

  Page 413 

Acquired Defects of Coagulation

This large and heterogeneous group of conditions includes:

Vitamin K Deficiency

Vitamin K, a fat soluble vitamin, is essential for synthesis of Factors II, VII, IX and X in the liver. Deficiency leads to spontaneous bleeding, e.g. into skin and mucous membranes, and failure of blood clotting.

In adults, deficiency may be due to

(a) MALABSORPTION (particularly of fat)
(b) DIETARY DEFICIENCY – rare – Vitamin K is widely distributed, e.g. in green vegetables, oils.
(c) INHIBITION – by COUMARIN anticoagulants, e.g. WARFARIN.
image

In neonates, vitamin K deficiency leads to bleeding – from GI tract and bruising. Breast milk contains little vitamin K – the disorder is uncommon in those receiving bottled milk. A severe deficiency may be seen in infants whose mothers took anticoagulants or anticonvulsants.

Liver Disease

The bleeding tendency in these patients is multifactorial.

image

This complicates bleeding, e.g. from OESOPHAGEAL varices.

‘Acquired Haemophilia’

Rarely, antibodies develop which block the effects of serum coagulation factors, especially Factor VIII. This may be idiopathic or follow auto-immune disease or drug treatment.

Disseminated Intravascular Coagulation (DIC) (see next page).

  Page 414 

Disseminated Intravascular Coagulation

In this disorder the coagulation system is activated, but the consumption of platelets and clotting factors which follows leads to a paradoxical bleeding tendency.

There are numerous causes:

(a) SEPTICAEMIA – especially gram negative septicaemia, – in meningococcal infections.
(b) SHOCK e.g. following severe burns.
(c) OBSTETRIC DISORDERS e.g. abruptio placentae, amniotic embolism, eclampsia.
(d) MALIGNANCY – especially acute promyelocytic leukaemia and mucin secreting adenocarcinomas (e.g. of stomach).
(e) IMMUNOLOGICAL DISORDERS e.g. autoimmune diseases, – incompatible blood transfusion.

The basic mechanism is as follows:

image

Patients frequently develop renal and hepatic failure and ‘shock lung’ [e.g. in the haemolytic uraemic syndrome (HUS) which is often associated with toxigenic E.coli infection – especially E.coli 0157 (see p.314)].

  Page 415 

Thrombophilia – Thrombotic Disorders

The major types, causes and effects of thrombosis are discussed on pages 159–163.

Recently, a group of inherited disorders has been discovered where deficiency of natural anticoagulants leads to an increased risk of venous thrombosis. This may be deep venous thrombosis in the lower limbs or visceral, e.g mesenteric veins. There is also an increased risk of pulmonary embolism.

The main forms are:

(a) ANTITHROMBIN DEFICIENCY

Antithrombin, a member of the SERPIN group of Serine protease inhibitors, is synthesised in the liver. It blocks the action of F IXa, F Xa, F XIa and thrombin. Deficiency is due to mutation of a gene on the long arm of chromosome 1 – the effects depend on the exact type of mutation. The prevalence is around 1 in 20 000.

Note: Heparin, the anticoagulant, acts by enhancing the action of antithrombin.

(b) PROTEIN C DEFICIENCY

This is a Vitamin K dependent protein, synthesised in the liver. Together with protein S it blocks the action of Factor Va and Factor VIIIa. Around 1 in 15–30 000 is affected. In addition to deep thrombosis, patients also get superficial thrombophlebitis.

(c) PROTEIN S DEFICIENCY

This protein is secreted by the liver, platelets and endothelial cells. Its function is to bind with protein C to inhibit Factors Va and VIIIa.

(d) ACTIVATED PROTEIN C RESISTANCE

This is an inherited disorder where a mutation affects the Factor V gene. The protein is resistant to the effects of protein C – simulating protein C deficiency.

The possible role of minor deficiencies of these genetic factors in the more common forms of thrombosis is not yet established. The well known risk factors for thrombosis are listed below.

Acquired risk factors for thrombosis include:

  Page 416 

Arterial Venous
ATHEROMA IMMOBILITY
SMOKING TRAUMA/SURGERY
HYPERTENSION MALIGNANCY
MYELOPROLIFERATIVE DISORDERS ORAL CONTRACEPTIVES
  OBESITY

The Lymphoid System

The lymphoid organs are principally involved in:

(a) Production and maturation of lymphocytes – thymus (T cells) and bone marrow (B cells).
(b) Antigen presentation and the immune response.
(c) ‘Filtration’ and phagocytosis of micro-organisms and particulate material.
image

Lymph Nodes

The basic structure reflects the main functions.

  Page 417 
image

Lymphadenopathy

Lymph node enlargement may be localised or generalised. It may be due to:

(a) reactive hyperplasia e.g.
infection by bacteria or viruses,
particulate material,
immune stimulation e.g. Rheumatoid arthritis,
draining degradation products from a cancer.
(b) due to neoplasia e.g.
secondary deposits of carcinoma,
primary lymphoid tumours.

Reactive Hyperplasia

Several patterns are seen.

  Page 418 
image

Lymphadenopathy – Infections

Acute Bacterial Lymphadenitis

This is seen draining an infected area.

image

Cat Scratch Disease

This infection by a bacterium Bartonella henselae follows scratching by an infected cat. Similar histology is seen in lymphogranuloma venereum, caused by Klebsiella granulomatis. A small transient painless genital ulcer is followed by inguinal lymphadenopathy (figure). The diagnosis can be confirmed by the Frei test (injection of purified chlamydial antigen stimulates a delayed hypersensitivity reaction).

  Page 419 
image

Lymphadenopathy

TUBERCULOSIS is associated with a granulomatous response (p.42), often with caseation; this is due to delayed type sensitivity.

image

VIRAL LYMPHADENITIS – Many infections induce paracortical hyperplasia – with activation of T cells.

In GLANDULAR FEVER (Infectious mononucleosis), an infection by Epstein–Barr virus of young adults, the cervical lymph nodes are particularly involved.

image

In MEASLES, the reactive nodes and lymphoid tissues generally contain unusual, multinucleate giant cells (Warthin–Finkeldey).

In TOXOPLASMOSIS, a protozoal disease (Toxoplasma gondii) which may cause serious damage to the fetus or neonate and present with lymph node enlargement in the adult, the histological appearances in the node may indicate the aetiology. The diagnosis is confirmed by serological tests.

  Page 420 
image

Lymphadenopathy – Non-Infective Causes

Foreign Material

Lymph nodes to which foreign particulate material drains often show marked enlargement due to accumulation of macrophages which have ingested the foreign material.

For example:

carbon and silica in hilar lymph nodes
silicone, e.g. in axillary lymph nodes in patients with prosthetic joints and breast implants.

CHRONIC SKIN DISEASE (so-called dermatopathic lymphadenopathy) e.g. psoriasis, eczema and mycosis fungoides (p.435).

image

Sarcoidosis

In this disease of unknown aetiology non-caseating granulomas are seen.

image

The appearances clearly resemble tuberculosis, but the granulomas remain discrete and there is no caseation.

Sarcoid type granulomas are also seen in the lymph nodes of patients with other granulomatous diseases, e.g. Crohn’s disease and in lymph nodes draining tumours.

  Page 421 

Spleen

The spleen is responsible for filtering the blood, phagocytosing debris and generating an immune response.

Normal average weight – 150 g.

image

Microscopic Appearance

image

The red pulp is the site of filtration and phagocytosis of the following:

1. Worn out cells and cell debris – especially blood cells but also cell debris derived from the body generally
2. Microbes and their toxins
3. Abnormal or excess material derived from metabolic processes.

Note: The special pores allowing re-entry of RBCs to the circulation have a 2μm aperture: abnormal RBCs (e.g. spherocytes) cannot pass through and are trapped.

  Page 422 

Splenomegaly

Enlargement of the spleen is an important and common clinical sign. Increase in the red pulp due to increased numbers of phagocytes and/or increased numbers of blood cells is the major component. In chronic infections, hyperplasia of the lymphoid tissue contributes.

  Page 423 

Enlargement is associated with:

1. infections
2. circulatory disturbances
3. disorders of the blood
4. neoplasia – primary and secondary
5. storage diseases and degenerations.

1. INFECTIONS

In acute systemic bacterial infections the spleen shows slight to moderate enlargement (200–400 g).

image
(a) Resolution as infection resolves.
(b) Occasionally spreads through capsule to adjacent tissues, with or without abscess formation.
(c) Only extremely rarely does abscess formation occur within the spleen.

In non-pyogenic and chronic infections, there may be moderate enlargement.

image

Examples: Infective endocarditis

Tuberculosis
Typhoid fever
Infectious mononucleosis
Brucellosis
In protozoal diseases – malaria and kala-azar – there is often massive enlargement
2. CIRCULATORY DISTURBANCES

Congestive splenomegaly occurs in two main conditions:

image

Splenomegaly associated with portal venous hypertension may have serious haematological effects (see Hypersplenism).

  Page 424 
3. DISORDERS OF THE BLOOD

Splenic enlargement is associated with blood disorders in two main circumstances:

1. Splenic enlargement causing blood disorders (hypersplenism).
image
2. Blood disorder causing splenic enlargement
image

Sometimes these two processes combine to form a vicious circle.

  Page 425 
image
4. NEOPLASIA
(a) primary – primary tumours of the spleen are rare with only occasional primary splenic lymphomas occurring.
(b) secondary – Splenic involvement by lymphoma and leukaemia is far commoner than by metastatic carcinoma.
image

Splenic enlargement may be a feature of Langerhans cell histiocytosis.

5. STORAGE DISEASES AND DEGENERATIONS

The diseases associated with this type of enlargement are rare.

Examples are:

Amyloidosis (see pp.22–24)
Lipid storage diseases (see p.21) including Gaucher’s disease, Niemann–Pick disease and Tay–Sachs disease.

Some disorders of glycogen storage.

  Page 426 

Diseases of the Spleen – Miscellaneous

Hyposplenism

Hyposplenism is not usually a cause of major disability. It occurs following splenectomy and in cases of splenic atrophy.

The effects are considered under two main headings:

  Page 427 
1. On the cells of the blood
image
2. On resistance to infection
image

Infarction

(i) Embolism causing infarction is not uncommon but usually clinically unimportant.
image
(ii) Enlarged spleens are particularly susceptible to infarction without embolism.
image

Thymus

This ‘primary’ lymphoid organ is concerned with the development and maturation of T lymphocytes which are then distributed to the lymphoid tissues and to the circulating pool.

image

This activity is maximal in the fetal and childhood stages. Involution is rapid after puberty.

image

Congenital Thymic Aplasia or Hypoplasia

The resulting T cell deficiency is associated with disordered cell-mediated immune response.

  Page 428 

Thymic Hyperplasia

This is associated with a number of conditions:

image

Auto-immune disorders,

e.g. Systemic lupus erythematosus

Addison’s disease
Thyrotoxicosis

Pancytopenia and NB myasthenia gravis

Thymic Tumours

Thymomas are rare epithelial tumours: with an admixture of lymphoid cells: they rarely metastasise. A small number are carcinomas. They may have auto-immune associations similar to thymic hyperplasia.

image

Other primary tumours arising in the thymus are;

(1) T cell lymphoblastic lymphomas (adolescent males)
(2) Hodgkin’s disease.
(3) Mediastinal large ‘B’ cell lymphoma
(4) Germ cell tumours (e.g. teratoma).
(5) Carcinoids.

The Thymus in Myasthenia Gravis (MG)

MG is a disease of voluntary muscles in which weakness is the main feature. The association with the thymus is striking in that 80% of all patients with MG have either thymic hyperplasia or thymoma.

Follicular hyperplasia (80%) – seen especially in young females.
Thymoma (20%) – seen especially in middle aged males.
The results of thymectomy in MG patients are very unpredictable.

The detailed pathological changes in MG and the mechanisms by which the thymus is linked with the disease are described on pages 109, pages 614.

  Page 429 

Neoplastic Lymphadenopathy

Lymph node enlargement may be due to

(a) Invasion by secondary tumours – especially carcinomas – or
(b) Primary lymphoid tumours – lymphomas.

Secondary Tumour Invasion

Carcinoma of the breast e.g.

Note:

(i) The nodal enlargement is not necessarily due to secondary tumour.
image

Reactive hyperplasia is also common in nodes draining tumours especially if there is ulceration. The distinction between these 2 causes of node enlargement can only be made with certainty by histological examination.

(ii) The invasion of a group of nodes occurs in a step-wise fashion: a single node (the sentinel node) is invaded initially and spread to adjacent nodes follows.
image

Lymphomas

Lymphomas are malignant tumours derived from lymphoid cells. They may arise within lymph nodes or at other sites (extra-nodal lymphomas).

Classically, they are divided into 2 main groups.

(a) Hodgkin’s disease 20–25%
almost always of lymph node origin.
characterised by the presence of Reed–Sternberg cells.
(b) Non-Hodgkin’s disease 75–80%
three-quarters arise in lymph nodes

In recent years, modern immunocytochemical, molecular biological and cytogenetic techniques have been applied to the study of lymphomas. The traditional division between Hodgkin’s and non-Hodgkin’s lymphoma has been challenged but remains of major clinical importance.

  Page 430 

Non-Hodgkin’s Lymphomas

These tumours mainly affect middle aged to elderly patients.

They may arise

image

Degree of Malignancy

The natural history tends to separate lymphomas into two main groups which have links with the morphological appearances.

1. Low grade malignancy associated with well differentiated relatively inactive cell types, – progress of years.
2. High grade malignancy associated with primitive actively proliferating cells, – progress over weeks or months.

Tend to respond well to chemotherapy.

  Page 431 

Pathological Complications

image

Classification

This is a confusing area. Traditional classifications relied on morphology alone. The World Health Organisation Classification (2008) which includes immunohistochemistry and genetic data is now generally accepted. A simplified version follows:

image

a) High Grade Tumours
Diffuse large B cell lymphoma.
Burkitt’s lymphoma.
Anaplastic large cell lymphomas (some do not express T cell markers).
b) Low Grade Tumours
Small lymphocytic lymphoma (equivalent to B-CELL, p.442).
Lymphoplasmacytic lymphoma.
Mantle cell lymphoma.
Follicular lymphoma.
Extranodal marginal zone B-cell lymphoma
Myeloma/Plasmacytoma.
T cell prolymphocytic leukaemia
Peripheral T cell lymphoma.
Adult T cell leukaemia.
Angioimmunoblastic T cell lymphoma.
Enteropathy-type T cell lymphoma.
Mycosis fungoides (skin).

According to this classification each type is considered separately for treatment purposes.

The classification relies on cell surface markers which distinguish the B and T cells and their subsets. B and T cell monoclonality can be detected by gene rearrangements, and some types of lymphoma have characteristic translocations.

Subtyping of lymphoma

Immunohistochemistry

image

Molecular Genetic Analysis

In B cell differentiation different immunoglobulin genes are found by gene rearrangements, while in T cell differentiation a similar process occurs with T cell antigen receptors (p.92).

  Page 432 
image

Follicular Lymphoma

This is one of the commonest forms – a ‘B’ cell lymphoma.

image

The neoplastic follicles are the malignant equivalent of normal germinal centres.

image

The tumour cells express the anti-apoptosis gene bcl–2 which immortalises them. There is often a translocation t (14;18) which joins the bcl–2 gene to the immunoglobulin heavy chain gene.

The lymphoma is slowly progressive but often eventually fatal. Sometimes it transforms into a diffuse large ‘B’ cell lymphoma (DLBCL).

Burkitt’s Lymphoma

This is a high grade lymphoma found mainly in Equatorial Africa, New Guinea and other malaria endemic areas. Similar tumours are seen in AIDS patients. The relationship with Epstein–Barr virus has already been discussed (p.81) – as has the translocation t (8;14) which activates the c-myc oncogene (p.152). The histological appearance is typical.

image

Endemic (African type) Burkitt’s lymphoma typically presents with lesions in the jaw, or in the abdomen, e.g. ovary, liver, gastrointestinal tract. The less common cases in the West typically involve lymph node, marrow and gut.

image

The disease may respond dramatically to aggressive treatment.

Diffuse Large B-Cell Lymphoma (DLBCL)

This is the commonest type of lymphoma and may arise in nodes or extra-nodal sites. They rapidly disseminate. They are composed of sheets of large round cells. About 50% of patients survive.

  Page 433 

Plasma Cell Tumours

Solitary Plasmacytoma

A very small number of plasma cell tumours are solitary at presentation, e.g. in a long bone, the nasopharynx, a lymph node, alimentary tract. In 50% of cases, multiple myeloma occurs within 10 years.

Multiple Myeloma (Myelomatosis)

image

The disease has an incidence of 10/100 000 per annum with an age peak in the 7th decade.

The median survival, even with treatment, is 3 years.

Pathological effects are considered under two main headings:

  Page 434 
1. Tumour growth and its effects
image
2. Synthesis of immunoglobulin and its effects

Myeloma, being a monoclonal tumour, will produce a single Ig. The common heavy chains are G (60%) and A (20%). In Waldenström’s macroglobulinaemia the immunoglobulin is always IgM.

Light chains of κ type are encountered more frequently than λ.

The presence of a single type of Ig is reflected in the electrophoretic pattern

The other normal immunoglobulins are always decreased.

image

In most cases high levels of ‘M’ protein cause:

1. High ESR
2. Marked rouleaux formation
3. Depending on type of Ig – increased blood viscosity.

Release of Light Chains

In many myelomas, some of the Ig molecules are incompletely formed, and unattached light chains are released with important effects. Because of their low molecular weight the light chains:

(1) Pass through the glomerular filtrate,
(a) appearing in the urine as Bence Jones protein (precipitates during heating – redissolves between 90 °–100 °C).
(b) During passage through the tubules the protein precipitates as casts and also damages the epithelial cells.
image
(2) Pass through capillaries
image

Infections, often of opportunistic type, and particularly pneumonias are common because the immune response is deficient since the high levels of ‘M’ protein are non-functioning.

  Page 435 

Non-Hodgkin’s Lymphoma – T Cell

Mycosis Fungoides

This is a primary T cell (CD4) lymphoma of the skin occurring usually in middle age. It presents as a scaly, red macule progressing to skin plaques and then nodules.

image

After many years the lymphoma may become generalised or exfoliate into the blood (Sézary syndrome).

Anaplastic Large Cell Lymphoma

The large malignant T cells (usually expressing surface marker CD30) often spread within the sinuses of the node and may mimic the cells in Hodgkin’s disease.

image

Although three-quarters of cases are of T cell type, the remainder are ‘null’ cell type, i.e. they express neither T nor B cell markers, causing further diagnostic difficulties. The cells express ALK-1 which resolves these difficulties.

The tumour shows 2 age peaks.

  Page 436 
image

Hodgkin’s Disease

Incidence

This disease accounts for 20% of lymphomas. It may occur at any age but there are 2 peaks of incidence.

image

Presentation

Most patients present with painless enlargement of one or more lymph node groups – cervical, axillary, mediastinal. One quarter complain of systemic ‘B’ symptoms (see Staging) – fever, night sweats, weight loss, itch. The risk of infections is increased by immunosuppression.

image
image

Staging (Ann Arbor system)

Stage I Disease involving single node or group of nodes
Stage II Disease in more than one site – all lesions either below or above the diaphragm
Stage III Disease on both sides of diaphragm
Stage IV Widespread involvement of extralymphoid sites ± lymph node involvement

The suffix (E) to the numeral indicates Extranodal disease, (A) denotes absence of systemic symptoms, (B) presence of these (see above).

  Page 437 

Hodgkin’s disease is diagnosed on the basis of distinctive large tumour cells known as Reed–Sternberg cells, which are now known to be ‘B’ cells of germinal centre origin.

image

There are two main types of Hodgkin’s disease:

  Page 438 
(a) Classical HD, probably caused by EBV. There are three main forms:
1. Nodular sclerosing (70%)
image
2. Mixed cellularity (20%)
image
3. Lymphocyte depleted (<2%)
image
(b) Nodular lymphocyte predominant Hodgkin’s disease (6%) This form affects young males and has a good prognosis. The ‘popcorn cells’ express ‘B’ cell markers and not CD30 of classic Hodgkin’s disease – it is an unusual ‘B’ cell lymphoma.
image

Leukaemias

Leukaemias are primary malignant tumours of haemopoietic cells.

image

Clinical Effects

The neoplastic cells replace the normal bone marrow

1. Deficiency of red cells → anaemia.
2. Deficiency of platelets → thrombocytopenia → bleeding.
3. Deficiency of white cells → infection.
4. Increased cell turnover → ↑DNA breakdown → ↑uric acid → gout.

Spread Of Leukaemia

Leukaemic cells circulate in blood and/or lymph and can therefore spread anywhere in the body. Nodular deposits are, however, uncommon.

  Page 439 
image

Classification

Leukaemias are classified according to the rate of progression and the lineage of the tumour cells. The 4 main forms are:

  MYELOID (granulocyte: monocyte series) LYMPHOID (B and T lymphocyte series)
ACUTE LEUKAEMIA
– Rapid progression
– Numerous primitive ‘blast’ cells.
(i) ACUTE
MYELOBLASTIC
LEUKAEMIA
(iii) ACUTE
LYMPHOBLASTIC
LEUKAEMIA
CHRONIC LEUKAEMIA
– Slow progression
– Cells almost mature.
(ii) CHRONIC
MYELOID
LEUKAEMIA
(iv) CHRONIC
LYMPHOCYTIC
LEUKAEMIA

Rare leukaemias affect red cells, megakaryocytes and plasma cells.

Aetiology

In most cases, the cause is unknown. Risk factors include:

1. Radiation, e.g. post Hiroshima, Chernobyl, therapeutic X-rays.
2. Chemicals, e.g. chemotherapy, benzene.
3. Genetic, e.g. Down’s syndrome.
4. Virus, e.g. Human T-cell Leukaemia Virus-1.

Cell Kinetics

Even in acute leukaemias, increased cell longevity beyond the normal (due to failure of response to mechanisms controlling ageing and destruction) is as important as proliferative rates in increasing the marrow cell population.

  Page 440 
image

Acute Myeloblastic Leukaemia

This is the commonest acute leukaemia of adults – 80% of patients are over 60 years old. Young adults and children may also be affected.

It may arise de novo or in association with chronic myeloid leukaemia, myeloproliferative disorders, myelodysplasia. The onset and progression to marrow failure is rapid, clinically presenting as anaemia, haemorrhage or serious infection.

The WHO classification describes four broad categories:

1. AML with recurrent genetic abnormalities. The differing genetic rearrangements have major implications for prognosis and treatment.
2. AML with multilineage dysplasia – usually following myelodysplastic syndrome.
3. AML, therapy related – usually after alkylating chemotherapy.
4. AML, not otherwise classified – a wide variety showing varying degrees of differentiation, e.g. acute monocytic, acute erythroblastic, acute myelomonocytic.

Pathology

image

Other organs may be involved: Splenomegaly, hepatomegaly and lymph node enlargement. More specific pathological clinical complications are seen in 2 subtypes.

  Page 441 
image

Chronic Myeloid Leukaemia (CML)

This form of leukaemia arises from malignant transformation of a primitive stem cell – but with the production of differentiated cells – particularly neutrophils.

This is a disease of middle age. There are 3 phases:

1. Chronic phase – a period of slow evolution – 2–6 years is typical.
2. Accelerated phase – an increase in immature cells.
3. Blast phase – transformation to an acute leukaemia – myeloblastic or, very rarely, lymphoblastic.

Rarely patients develop myelofibrosis with marrow failure.

image

Philadelphia (Ph) Chromosome

In over 95% of cases of CML there is a specific cytogenetic change t(9;22)(q34;q11) with the formation of the ‘Ph chromosome’.

The change involves a translocation of the c-abl gene (an oncogene) from chromosome 9 to chromosome 22 where hybridisation with the bcr gene occurs. A tyrosine kinase inhibitor (IMATINIB) which targets this pathway has been introduced.

  Page 442 

Chronic Lymphocytic Leukaemia

This is a common form of leukaemia (25% of all cases) and particularly affects middle aged and elderly patients. It is a monoclonal proliferation of small lymphocytes and is best regarded as the leukaemic form of lymphocytic lymphoma.

Most cases are of B cell type – less than 5% are of T cell lineage.

There is typically lymph node enlargement and splenomegaly.

image

The lymph node and splenic architecture is obscured by closely packed small lymphocytes.

Mitotic activity is minimal, but very small foci of larger active cells (proliferation centres) are the source of new neoplastic cells.

Germinal centres destroyed by infiltrating lymphocytes

In some cases the lymphoid enlargement precedes the leukaemic phase.

image

In addition to anaemia these patients often suffer recurrent infections due to defective immunity.

In a minority of cases (approximately 5%) transformation to a high grade ‘B’ cell lymphoma results (Richter syndrome).

  Page 443 

Acute Lymphoblastic Leukaemia (ALL)

This term describes a group of leukaemias of lymphocytic precursors. ALL is the commonest form of childhood leukaemia but is also seen in adults.

Like AML, immunological and genotypic classification is increasingly important. Broadly, they are classified as follows:

Precursor B cell > 80%
Precursor T cell 15%
Null cell.

ALL in Childhood

This is usually of Precursor B ALL type

image

Childhood ALL is now potentially curable – 70% survive 5 years.

ALL in Adults

Adults have a worse prognosis and often require bone marrow transplantation as well as chemotherapy.

  Page 444 

Myeloproliferative Disorders

In this group of diseases, neoplastic transformation of a haemopoietic precursor cell may lead to excess production of erythrocyte, leucocyte or platelet precursors. In many cases more than one element is affected. Transformation to acute leukaemia can occur in all forms. This can be summarised as follows:

image

In these conditions excess marrow proliferation may be seen in liver, spleen and other organs – extramedullary haemopoiesis (EHM).

Myelofibrosis

When haemopoietic cellular proliferation is overshadowed by progressive fibrosis of the marrow, splenomegaly (often of massive proportions) due to extramedullary haemopoiesis is often found.

Marrow: ordinary marrow puncture usually results in a ‘dry tap’, therefore trephine or cutting needle biopsy is required

image

2. Myelodysplastic Syndromes (MDS)

These are primary disorders of stem cells associated with several different chromosomal abnormalities. They lead to ineffective haemopoiesis of varying types, with the appearance in the peripheral blood of abnormal cells. A significant number progress to leukaemia.